Therapeutically, rheumatoid arthritis treatment that reduces IL-17-driven inflammation can coincide with improved periodontal parameters, and periodontal care may attenuate the systemic inflammatory burden in rheumatoid arthritis [7,39]. Here, IL17A is linked to rheumatoid arthritis.